Effects of chronic typical and atypical antipsychotic drug treatment on maternal behavior in rats

Ming Li, Radek Budin, Alison S. Fleming, Shitij Kapur

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Understanding the effects of antipsychotics on maternal behavior is important for understanding the poor quality of mother-infant interaction in schizophrenia. Previous preclinical work has demonstrated that acute treatment with typical and atypical antipsychotics disrupts maternal behavior. However, the effects of chronic antipsychotic treatment on maternal behavior are unknown. This issue is of importance since clinical use of antipsychotic medication requires continuous exposure to these drugs. In this study, we treated postpartum rats with haloperidol (0.25 mg/kg/day) or olanzapine (7.5 mg/kg/day), via osmotic minipumps or daily injections for 3 weeks. Maternal behavior was assessed every third day. On each observation day, maternal behavior was observed twice, once just prior to the daily injection ("trough" as this was 24 h after last injection) and again 2 h after the injection ("peak"). Daily injections of haloperidol and olanzapine significantly disrupted pup retrieval, pup licking, nest building at peak, but this effect was gone by trough. Drug administration via minipumps also disrupted these behaviors, but the effects were less severe. Pup nursing was enhanced by either method of drug administration. No evidence of sensitization or tolerance associated with chronic drug treatment was found. It is concluded that chronic antipsychotic treatment disrupts active maternal behaviors and this disruption, most likely to lead to side effects in humans, should be avoided in future drug development.

Original languageEnglish (US)
Pages (from-to)325-336
Number of pages12
JournalSchizophrenia Research
Volume75
Issue number2-3
DOIs
StatePublished - Jun 15 2005

Fingerprint

Maternal Behavior
Antipsychotic Agents
olanzapine
Injections
Pharmaceutical Preparations
Haloperidol
Therapeutics
Mother-Child Relations
Postpartum Period
Schizophrenia
Nursing
Observation

Keywords

  • Haloperidol
  • Maternal behavior
  • Olanzapine
  • Osmotic minipumps
  • Rat

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Biological Psychiatry

Cite this

Effects of chronic typical and atypical antipsychotic drug treatment on maternal behavior in rats. / Li, Ming; Budin, Radek; Fleming, Alison S.; Kapur, Shitij.

In: Schizophrenia Research, Vol. 75, No. 2-3, 15.06.2005, p. 325-336.

Research output: Contribution to journalArticle

Li, Ming ; Budin, Radek ; Fleming, Alison S. ; Kapur, Shitij. / Effects of chronic typical and atypical antipsychotic drug treatment on maternal behavior in rats. In: Schizophrenia Research. 2005 ; Vol. 75, No. 2-3. pp. 325-336.
@article{7f3a4e6116c14f79a7d729a9921a9dae,
title = "Effects of chronic typical and atypical antipsychotic drug treatment on maternal behavior in rats",
abstract = "Understanding the effects of antipsychotics on maternal behavior is important for understanding the poor quality of mother-infant interaction in schizophrenia. Previous preclinical work has demonstrated that acute treatment with typical and atypical antipsychotics disrupts maternal behavior. However, the effects of chronic antipsychotic treatment on maternal behavior are unknown. This issue is of importance since clinical use of antipsychotic medication requires continuous exposure to these drugs. In this study, we treated postpartum rats with haloperidol (0.25 mg/kg/day) or olanzapine (7.5 mg/kg/day), via osmotic minipumps or daily injections for 3 weeks. Maternal behavior was assessed every third day. On each observation day, maternal behavior was observed twice, once just prior to the daily injection ({"}trough{"} as this was 24 h after last injection) and again 2 h after the injection ({"}peak{"}). Daily injections of haloperidol and olanzapine significantly disrupted pup retrieval, pup licking, nest building at peak, but this effect was gone by trough. Drug administration via minipumps also disrupted these behaviors, but the effects were less severe. Pup nursing was enhanced by either method of drug administration. No evidence of sensitization or tolerance associated with chronic drug treatment was found. It is concluded that chronic antipsychotic treatment disrupts active maternal behaviors and this disruption, most likely to lead to side effects in humans, should be avoided in future drug development.",
keywords = "Haloperidol, Maternal behavior, Olanzapine, Osmotic minipumps, Rat",
author = "Ming Li and Radek Budin and Fleming, {Alison S.} and Shitij Kapur",
year = "2005",
month = "6",
day = "15",
doi = "10.1016/j.schres.2004.09.012",
language = "English (US)",
volume = "75",
pages = "325--336",
journal = "Schizophrenia Research",
issn = "0920-9964",
publisher = "Elsevier",
number = "2-3",

}

TY - JOUR

T1 - Effects of chronic typical and atypical antipsychotic drug treatment on maternal behavior in rats

AU - Li, Ming

AU - Budin, Radek

AU - Fleming, Alison S.

AU - Kapur, Shitij

PY - 2005/6/15

Y1 - 2005/6/15

N2 - Understanding the effects of antipsychotics on maternal behavior is important for understanding the poor quality of mother-infant interaction in schizophrenia. Previous preclinical work has demonstrated that acute treatment with typical and atypical antipsychotics disrupts maternal behavior. However, the effects of chronic antipsychotic treatment on maternal behavior are unknown. This issue is of importance since clinical use of antipsychotic medication requires continuous exposure to these drugs. In this study, we treated postpartum rats with haloperidol (0.25 mg/kg/day) or olanzapine (7.5 mg/kg/day), via osmotic minipumps or daily injections for 3 weeks. Maternal behavior was assessed every third day. On each observation day, maternal behavior was observed twice, once just prior to the daily injection ("trough" as this was 24 h after last injection) and again 2 h after the injection ("peak"). Daily injections of haloperidol and olanzapine significantly disrupted pup retrieval, pup licking, nest building at peak, but this effect was gone by trough. Drug administration via minipumps also disrupted these behaviors, but the effects were less severe. Pup nursing was enhanced by either method of drug administration. No evidence of sensitization or tolerance associated with chronic drug treatment was found. It is concluded that chronic antipsychotic treatment disrupts active maternal behaviors and this disruption, most likely to lead to side effects in humans, should be avoided in future drug development.

AB - Understanding the effects of antipsychotics on maternal behavior is important for understanding the poor quality of mother-infant interaction in schizophrenia. Previous preclinical work has demonstrated that acute treatment with typical and atypical antipsychotics disrupts maternal behavior. However, the effects of chronic antipsychotic treatment on maternal behavior are unknown. This issue is of importance since clinical use of antipsychotic medication requires continuous exposure to these drugs. In this study, we treated postpartum rats with haloperidol (0.25 mg/kg/day) or olanzapine (7.5 mg/kg/day), via osmotic minipumps or daily injections for 3 weeks. Maternal behavior was assessed every third day. On each observation day, maternal behavior was observed twice, once just prior to the daily injection ("trough" as this was 24 h after last injection) and again 2 h after the injection ("peak"). Daily injections of haloperidol and olanzapine significantly disrupted pup retrieval, pup licking, nest building at peak, but this effect was gone by trough. Drug administration via minipumps also disrupted these behaviors, but the effects were less severe. Pup nursing was enhanced by either method of drug administration. No evidence of sensitization or tolerance associated with chronic drug treatment was found. It is concluded that chronic antipsychotic treatment disrupts active maternal behaviors and this disruption, most likely to lead to side effects in humans, should be avoided in future drug development.

KW - Haloperidol

KW - Maternal behavior

KW - Olanzapine

KW - Osmotic minipumps

KW - Rat

UR - http://www.scopus.com/inward/record.url?scp=18844396415&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=18844396415&partnerID=8YFLogxK

U2 - 10.1016/j.schres.2004.09.012

DO - 10.1016/j.schres.2004.09.012

M3 - Article

C2 - 15885524

AN - SCOPUS:18844396415

VL - 75

SP - 325

EP - 336

JO - Schizophrenia Research

JF - Schizophrenia Research

SN - 0920-9964

IS - 2-3

ER -